Medicines News

News

Covid-19 vaccine roll-out expected in less than 3 months in UK: Report

Scientists working on the Oxford vaccine hope regulators approve it before the beginning of 2021

1 min read3 Oct 2020
News

EU agency starts ’rolling review’ to speed OK for Covid-19 vaccine

The EU regulator said instead of waiting for all of the required vaccine data to be submitted before beginning its assessment, the EMA has begun analyzing the preliminary information from scientists on the Oxford vaccine

2 min read1 Oct 2020
Industry

Medicine factories are yet to get back to 50% of capacity

Most medicine factories are running at 50% of capacity or less because of the lack of manpower and also because local authorities are not giving permission for the units to functionIndustry officials believe the situation could deteriorate for the industry if the nationwide lockdown continues

1 min read29 Apr 2020
Companies

Pharma distribution chains trip over hurdles to logistics

Chemists worry that disruption may worsen as local authorities hamper shipmentsShipments from factories affected as staff is either not turning up or being stopped by police

2 min read26 Mar 2020
News

Economic Survey: Free medicines not really free for most patients

More than 60% of the patients are still forced to pay for some of the medicines they receive

3 min read2 Feb 2020
Companies

49 medicine samples fail regulator’s quality tests

A sample of Torrent Pharma’s anti-hypertension drug Lorvas also failed the testDuring the inspections in Dec, the CDSCO also found a counterfeit sample of Abbott India’s Udiliv 300

1 min read15 Jan 2020
News

NPPA raises ceiling price of 21 essential medicines by 50%

These essential life saving medicines include BCG vaccine, anti-malaria drug Chloroquine, anti-leprosy drug DapsoneThe increase in prices of these key drugs was on account of a sharp rise in the cost of active pharmaceutical ingredients from China

2 min read13 Dec 2019
News

Govt working on policy to allow OTC drugs sale on retail outlets

Govt’s advisory board for pharmaceutical policy to consider allowing sale of certain OTC medicines at retail outletsLast month, a panel had recommended that the government should define OTC drugs in the Drugs and Cosmetics Rules

1 min read29 Oct 2019
Politics

Govt initiates new process to identify essential medicines

Committee to meet stakeholders tomorrow to shortlist drugs that should be available in assured qualityStakeholders have been asked for their feedback on cardiology and cancer drugs

2 min read23 Jul 2019
Companies

Health ministry prepares rebuttal to USTR’s counterfeit medicines report

Dismissing the report, Arun Singhal, Additional Secretary in the health ministry told Mint that the government is in the process of drafting a rebuttalIn its latest Special 301 report released by the USTR, it claimed that India and China were the leading sources of counterfeit medicines

2 min read5 May 2019
Load More

Popular Topics

Budget

The Union Budget contains details about the estimated receipts and the expenditure of the government for a particular fiscal year. The Budget is allotted for the upcoming fiscal year, which runs from 1st April to 31st March of the next year. Here is a quick guide on how the Union Budget is prepared

25 Articles

Byju's

Ever since Byju Raveendran founded the eponymous edtech company in 2011, Byju's has been the subject of much discussion. The Indian education sector seemed ripe for disruption, and by 2019, the company was an investor favourite. The onset of the pandemic brought the real riches for Byju's: with kids attending school through their laptops, phones, and tablets, Byju's was immediately seen as being at the forefront of facilitating this institutional method of learning — all the way to a $22 billion valuation.  But with the accolades, came the woes. As Covid-19 slipped into the rear-view mirror, ugly stories about the edtech's policies came to light. Impossible targets, poor management, and a slew of senior-level exits dominated the headlines. Finally, came the last straw — investors and regulators started asking the tough questions about the company failing to comply with statutory requirements. Growth, it seemed, had come at the cost of governance, like in so many messy startups.  Here’s a curation of original reportage and analysis about Byjus, once India’s most valuable startup.

3 Articles
HomeMarketsPremiumInstant LoanMint Shorts